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Abstract. Blue rubber-bleb naevus (BRBN)  syndrome is 
a rare disorder characterized by subcutaneous and gastro- 
intestinal haemangiomas. The latter may lead to bleed- 
ing complications. A case is reported in which a process 
of chronic intravascular coagulation resulted in serious 
thrombotic omplications. In the presence of a chronic 
consumption coagulopathy, it remains uncertain whether 
antiplatelet drugs are of prophylactic antithrombotic 
value. 
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Introduction 
In 1958 Bean [2] described a syndrome consisting of 
haemangiomatous malformations located in the skin and 
gastro-intestinal tract and named it Blue rubber-bleb 
naevus syndrome (BRBN)  as the cavernous haemangio- 
mas took like rubber nipples. Most cases are sporadic, 
although an autosomal dominant pattern of  inheritance 
has been suggested [5]. BRBN syndrome in most cases is 
present from birth or early chi ldhood and may be com- 
plicated by gastro-intestinal bleeding and orthopaedic 
abnormalities. According to strict criteria only 21 cases 
in the paediatric age group have so far been reported. 
Treatment of BRBN syndrome and its various complica- 
tions is mainly symptomatic [8]. 
lings distributed over the body. Though present since birth, rapid 
growth of the lesions had been observed uring several months be- 
fore admission. There was also a history of chronic pallor. The par- 
ents were not consanguinous and there were no family members 
known to have the same disorder. 
On physical examination the skin was pale with no bruising. 
Many bluish subcutaneous nodules were noted, located on the 
right half of the chest, the extremities (Fig. 1) and the vulva. On 
palpation the consistency ofthese haemangiomas was soft and rub- 
ber-like. 
Investigations to document the presence of non-cutaneous 
haemangiomas were undertaken. X-ray series of the upper and 
lower gastro-intestinal tract showed no abnormalities after barium- 
contrast intake. Superior mesenteric arteriography revealed a 5 cm 
area at the ileo-coecal region compatible with haemangiomatosis. 
On colonoscopy a vascular bleb was seen on the sigmoidorectal 
border and two similar lesions in the distal part of the descendent 
colon. Laboratory investigations (Table 1) on admission i  1979 in- 
dicated the presence of a consumption coagulopathy. The pres- 
ence of a microangiopathic aemolytic anaemia was indicated by a 
low haptoglobin, a mildly increased reticulocyte count and in par- 
ticular by the presence of schistocytes. At the same time a mild 
Case report 
An l i5-year-old girl was admitted to the Sophia Children's Hospi- 
tal in March 1979 for investigation of multiple blue painless swel- 
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Abbreviation: BRBN = Blue rubber-bleb naevus yndrome Fig.1. Blue rubber-bleb naevus lesions on the feet with secondary 
phlebectasias 
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Table 1. Laboratory results. A: initially; B: during manifest throm- 
bosis; C: during antiplatelet therapy; D: off antiplatelet therapy 
A B C D 
(1979) (1985)  (1986)  (1987) 
Hb (g/dl) 6.4 9.6 10.4 10.8 
Ht (%) 23 34 32 33 
Erythrocyte 3.6 4.0 3.6 3.5 
count/gl 
Reticulocytes (%o) 32 35 26 26 
Haptoglobin (g/l) < 0.38 < 0.38 < 0.38 < 0.38 
Schistocytes Present Present Present Present 
Thrombocyte count 250 90 134 120 
(• 109/1) 
APTT (28-33 sec) 31 30 28 26 
Fibrinogen (Clauss) 0.8 0.7 1.2 0.9 
(g/l) 
Fibrin(ogen) 30-40 80-100 80-100 100-120 
degradation 
products (latex) 
(gg/ml) 
Fibrin monomers Not done Present Present Present 
Initial Throm- Therapy After 
bosis therapy 
Stage 
Fig. 2. Blood smear: note the "jig-saw puzzle" variant of schisto- 
cytes as a result of microangiopathic haemolytic anaemia 
iron deficiency was found and positive results were obtained for 
faecal occult blood loss. 
A conservative therapeutic approach was initially applied. 
Oral iron therapy was prescibed. Compression bandages of the 
legs were tried, but without success. The patient then discontinued 
her visits to the out-patient department. Five years later she re- 
turned, by which time the skin lesions had become more extensive. 
Laboratory evaluation again showed th  presence of a chronic 
consumption coagulopathy with micro-angiopathic haemolytic 
anaemia (Table 1 and Fig. 2). 
The patient was now no longer iron deficient and repeated 
analyses revealed no occult gastro-intestinal blood loss. 
In the spring of 1985 she was admitted in a critically ill condi- 
tion with a temperature of 40~ Intraveneous antibiotics were 
started (first gentamicin a d cefamandole, later penicillin G, 6 • 
1250000 intravenously). Pneumococci were isolated from blood 
cultures. During this period a painful swelling of the right leg de- 
veloped and an evident clinical diagnosis of deep venous (ileo- 
femoral) thrombosis was made, which was confirmed by ultra- 
sound investigations. A  a result of this complication she became 
unable to walk and extensive revalidation therapy had to be insti- 
tuted. 
Prophylactic antithrombotic therapy with low dose aspirin 
(3 mg/kg per day) and dipyramidole (4 mg/kg per day) was tarted 
and continued for a period of 12 months. Revalidation therapy was 
succesful and very careful monitoring did not reveal any gastro-in- 
testinal bleeding during the observation period. 
Though no dramatic changes in the haemostatic profile were 
observed, thrombocyte counts remained above 100 • 109/1 and fi- 
brinogen levels remained above 1.0g/1 during the period of anti- 
platelet therapy. 
Discussion 
Haemostatic abnormalities have not been previously re- 
ported in BRBN-syndrome, except for thrombocyto- 
paenia in the case of Fretzin and Potter [4]. In our pa- 
tient the presence of a consumption coagulopathy is doc- 
umented. In localised giant haemangiomas this is known 
as Kasabach-Merritt syndrome [6]. In this syndrome 
trapping of platelets and their subsequent activation re- 
sults in a process of localized intravascular coagulation 
with consumption of clotting factors [7, 9]. Consumption 
coagulopathy causes an instability of the thrombohaem- 
orrhagic balance. This may lead to acute bleeding com- 
plications, but - in contrast - may also predispose to 
thrombotic omplications. Our patient presented with 
manifest hrombosis during a period of severe infection 
and prolonged immobilisation, so called "thrombogenic 
circumstances". 
Active treatment of a consumption coagulopathy be- 
comes necessary in the presence of either bleeding or 
thrombosis. However, in this case of BRBN syndrome 
consumption coagulopathy can neither be treated by 
complete removal or eradication of the vascular malfor- 
mations nor by generating local thrombosis [10] in the 
widespread haemangiomas. Various drugs have been re- 
ported to improve the coagulopathy in Kasabach-Merritt 
syndrome, including heparin [3] and corticosteroids [1]. 
Long-term therapy with aspirin and dipyramidole was 
reported by Koerper et al. [7]. This treatment resulted in 
an improvement in platelet count and clotting factor ab- 
normalities and prevented clinical bleeding problems. 
By a stabilising effect on the haemostatic equilibrium 
this therapy may diminish the risk of both haemorrhagic 
and thrombotic derangements. 
This report illustrates that the presence of a chronic 
consumption coagulopathy in BRBN syndrome may lead 
to manifest hrombotic omplications, either by its na- 
ture or precipitated by so called "thrombogenic circum- 
stances", i.c. pneumococcal septicaemia and immobilisa- 
tion. 
The possible prophylactic antithrombotic value of 
long-term therapy with low dose aspirin and dipyrami- 
dole in these circumstances remains uncertain. 
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OSLER'S PERSONAL IDEALS 
I have had three personal  ideals. One,  to do the day's work  well  and not  to bother  
about  tomorrow.  The second ideal  has been to act the Go lden  Rule,  as far as in me 
lay, toward  my profess ional  brethren and towards the pat ients commit ted  to my 
care. And  the third has been to cult ivate such a measure of equanimity  as would 
enable me to bear  success with humil i ty,  the affection of  my fr iends without pr ide,  
and to be ready when the day of sorrow and grief come to meet  it with courage be-  
f itting a man. 
Osler, in his Speech in May,  1905, 
at the Farewel l  D inner  of the Medica l  profess ion of Amer ica  and Canada,  
when he was bound for Oxford 
